An Open Protocol for the Compassionate Use of Trametinib

Trial Profile

An Open Protocol for the Compassionate Use of Trametinib

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 18 Sep 2015

At a glance

  • Drugs Trametinib (Primary)
  • Indications Cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 10 Feb 2015 New trial record
    • 09 Feb 2015 Study objective and patient inclusion criteria changed to include the segment ''the development of tumors is associated with pathological skin disease mutation V600E or V600K'', as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top